Dren Bio
Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.
$350MPrivate financing
ParticipantActivity from announced rounds
Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.
Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders.
Crossbow Therapeutics develops antibody therapies for cancer.